1[4]Landolfi R,Marchioli R,Kutti J,et al.Efficiency and safety of low-dose asp irin in polycythem ia vera.N Engl J Med,2004,350(2):99.
2[5]Landolfi R,Marchioli R,Kutti J,et al.Efficacy and safety of low-dose asp irin in polycythem ia vera.N Engl J Med,2004,350(2):114.
3[6]Bilgram IS,Greenberg BR.Polycythem ia rubra vera.Sem in Oncol,1995,22(4):307-26.
4Anderson FA Jr,Wheeler HB. Physician practices in the management of venous thromboembolism:a community-wide survey. J Vsac Surg ,1992,16:707-714.
5Stein PD,Patel KC,Kalra NK,et al.Deep venous thrombosis in a general hospital.Chest, 2002, 122:960-962.
6Cook D, McMullin J, Hodder R,et al.Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey.Crit Care, 2001,5:336-342.
7Rathbun SW, Raskob GE, Whitsett TL. Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med, 2000,132:227-232.
8Fedullo PF,Tapson VF.Clinical practice. The evalution of suspected pulmonary embolism.N Engl J Med,2003,349:1247-1256.
9Oger E,Leroyer C,Le Moigne E,et al.The value of a risk factor analysis in clinically suspected deep venous thrombosis. Respiration,1997,64:326-330.
10Tai YF. An Association between atherosclerosis and venous thrombosis.N Engl J Med, 2003, 349:401-402.
